<DOC>
	<DOCNO>NCT00133627</DOCNO>
	<brief_summary>Medications available treatment seasonal allergic conjunctivitis include antihistamine . These medicine block release histamine , substance body release allergic reaction occur . Novartis ( NVS ) develop eye drop formulation well tried antihistamine call ketotifen . This study compare efficacy tolerability ketotifen eye drop emedastine , popular treatment seasonal allergic conjunctivitis China .</brief_summary>
	<brief_title>Ketotifen Ophthalmic Solution With Emedastine Patients With Seasonal Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Ketotifen</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Age 3 year old . History seasonal allergic conjunctivitis Presence bilateral ocular itching/conjunctival hyperaemia ( redness ) baseline : 1. least intensity degree 2 itching , 2. least intensity degree 4 composite score itch conjunctival hyperaemia Other systemic/ophthalmic condition Presence form allergic conjunctivitis seasonal allergic conjunctivitis ( e.g . perennial allergic conjunctivitis , vernal keratoconjunctivitis , atopic keratoconjunctivitis , giant papillary conjunctivitis ) . Active bacterial viral conjunctivitis history ocular herpes . Presence history severe dry eye . Previous treatment Any systemic ocular corticosteroid within two ( 2 ) week prior randomization . Any systemic ocular mast cell stabilizer within two ( 2 ) week prior randomization . Any ophthalmic medication within three ( 3 ) day prior randomization . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Allergic</keyword>
	<keyword>Conjunctivitis</keyword>
	<keyword>Ketotifen</keyword>
	<keyword>Histamine</keyword>
</DOC>